SCHEMBL3149886

SCHEMBL3149886

OC[C@H]1OC(O[C@@H]2[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@H](CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 1/20 0.57
▸ LGALS3 P17931 1/20 0.57
▸ LGALS4 P56470 1/20 0.57
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ AMY2A P04746 2/20 0.51
▸ ENGASE Q8NFI3 1/20 0.50
▸ CD209 Q9NNX6 1/20 0.50
▸ FGF1 P05230 1/20 0.47
▸ FGF2 P09038 1/20 0.47
▸ VEGFA P15692 1/20 0.47
▸ HPSE Q9Y251 1/20 0.47
▸ TYR P14679 2/20 0.47
▸ AMY1A P0DUB6 1/20 0.47
▸ TSHR P16473 2/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ GJA1 P17302 1/20 0.46
▸ GJB2 P29033 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31614391 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL31701579 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL31700326 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL31700334 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL31614389 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL295024 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL31614393 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL295220 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL21243223 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL31700630 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103282508-B Non-reducing end modified glucan, Its Preparation Method And Use 江崎格力高株式会社 2016-09-21 — — CN disclosed
EP-2636749-B1 NON-REDUCING END-MODIFIED GLUCAN, METHOD FOR PRODUCING SAME, AND USE THEREOF EZAKI GLICO CO (JP) 2016-08-03 — — EP disclosed
US-20130295163-A1 NON-REDUCING END MODIFIED GLUCAN, METHOD FOR PRODUCING SAME, AND USE THEREOF EZAKI GLICO CO., LTD. (JP) 2013-11-07 — — US disclosed
EP-2636749-A1 NON-REDUCING END-MODIFIED GLUCAN, METHOD FOR PRODUCING SAME, AND USE THEREOF Ezaki Glico Co., Ltd. (JP) 2013-09-11 — — EP disclosed
CN-103282508-A Non-reducing end-odified glucan, method for producing same, and use thereof EZAKI GLICO CO 2013-09-04 — — CN disclosed
EP-1008853-B1 Reagent compositions for measuring electrolyte using alpha-amylase TOYO BOSEKI (JP) 2010-03-10 — — EP disclosed
US-6387646-B1 KIT INCLUDES CHELATING AGENT AND DEACTIVATED ALPHA-AMYLASE WHICH CAN BE REACTIVATED, COMPONENTS ARE KEPT SEPARATE; FOR TESTING BLOOD AND URINE TOYO BOSEKI KABUSHIKI KAISHA (JP) 2002-05-14 — — US disclosed
EP-1008853-A2 Reagent compositions for measuring electrolyte using alpha-amylase Toyo Boseki Kabushiki Kaisha (JP) 2000-06-14 — — EP disclosed
Send feedback